An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects
Clinical trial NCT02409524 · COMPLETED
Trial details
- NCT number
- NCT02409524
- Sponsor
- Mirror Biologics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-06-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.